ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 4

Rheumatoid Arthritis (RA)-Related Joint Symptoms and Thoracic Bone Mineral Density in an RA-Free Community Dwelling Population

Jan M. Hughes-Austin1, Joachim H. Ix2, Samuel R. Ward3, M. Kristen Demoruelle4, V. Michael Holers5, Jill M. Norris6 and Kevin D. Deane7, 1Orthopaedic Surgery, University of California, San Diego, La Jolla, CA, 2University of California, San Diego, La Jolla, CA, 3Radiology, Orthopaedic Surgery, and Bioengineering, University of California, San Diego, La Jolla, CA, 41775 Aurora Ct, 1775 Aurora Ct, Aurora, CO, 5Rheumatology Division, University of Colorado School of Medicine, Aurora, CO, 6University of Colorado Denver, Aurora, CO, 7Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Auto-immunity, Bone density, Epidemiologic methods, joint damage and spine involvement

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Epidemiology and Public Health - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoporosis, defined by Tscore < -2.5, is one of the main consequences of RA and it appears early in the disease. It is twice as prevalent in RA as it is in the general population; and low bone mineral density (BMD) in RA is associated with increased risk of hip and vertebral fractures. It is not known exactly whether this degeneration begins in pre-clinical RA and whether joint symptoms provide clinicians insight into these degenerative changes, especially in the spine. Therefore, we investigated associations between RA-specific joint symptoms and thoracic BMD in a community-based cohort free of RA.

Methods: We evaluated associations between presence of RA-specific joint symptoms and thoracic BMD (tBMD) using computed tomography (CT) in 31 individuals from the Studies of the Etiology of RA who were RA-free based on the 1987 ACR and 2010 ACR/EULAR criteria for RA. A physician confirmed joint swelling; participants self-reported stiffness and pain in the wrist, elbow, or any metacarpophalangeal, proximal interphalangeal, or metatarsophalangeal joints. Thoracic BMD on CT was measured using OsiriX 7.5 (Pixmeo, Geneva, Switzerland), and calculated using average BMD of T7-T9 vertebrae. Sex-specific Tscores were calculated as follows: T(female) = (BMD(individual mean) – 222)/36; T(male) = (BMD(individual mean) – 215)/33; where < -2.5 is considered osteoporosis and < -1.0 is considered osteopenia. Associations between joint symptoms and tBMD were evaluated using ANCOVA and adjusted for age, race, body mass index (BMI), pack-years smoking, high sensitivity c-reactive protein (CRP), number of autoantibodies (Anti-CCP, RF-IgG, RF-IgM, RF-IgA), and the source of their recruitment into SERA (as a first degree relative or health fair participant).

Results: Among 31 SERA participants, average(SD) age was 54(13), BMI was 27(5), CRP was 3(4), Tscore was -1(2), 45% were women, 94% were non-Hispanic White, and everyone had an average of 1(1) autoantibody. Joint swelling was associated with lower Tscores, although the association was marginally significant (p=0.08). Neither joint stiffness nor pain was associated with Tscores (Table).

Conclusion: In a cohort of RA-free individuals, neither joint swelling, stiffness, nor pain was significantly associated with tBMD Tscores. These preliminary data were limited by small sample size. Joint swelling was marginally associated with tBMD, thus future research with larger sample size is required to determine whether joint swelling may be linked to bone density.  

Table. Associations between joint symptoms and thoracic BMD presented as a Tscore

Tscore

n (%) positive

B (SD)

p-value

Joint Swelling

2 (6)

Age, race, cohort adjusted

-1.49 (0.8)

0.0837

Fully adjusted*

-1.70 (0.9)

0.0823

Joint Stiffness

5 (16)

Age, race, cohort adjusted

-0.27 (0.6)

0.6541

Fully adjusted*

-0.37 (0.7)

0.5793

Joint Swelling+Stiffness

7 (23)

Age, race, cohort adjusted

-0.79 (0.5)

0.1429

Fully adjusted*

-0.98 (0.6)

0.1087

Joint Pain

7 (23)

Age, race, coh
ort adjusted

-0.38 (0.5)

0.4826

Fully adjusted*

-0.62 (0.6)

0.3115

*Fully adjusted for age, race, BMI, pack-years smoking, CRP, number of autoantibodies, cohort (FDR vs Health Fair)

Disclosure: J. M. Hughes-Austin, None; J. H. Ix, None; S. R. Ward, None; M. K. Demoruelle, None; V. M. Holers, Patents, 9; J. M. Norris, None; K. D. Deane, Inova Diagnostics, Inc., 9.

To cite this abstract in AMA style:

Hughes-Austin JM, Ix JH, Ward SR, Demoruelle MK, Holers VM, Norris JM, Deane KD. Rheumatoid Arthritis (RA)-Related Joint Symptoms and Thoracic Bone Mineral Density in an RA-Free Community Dwelling Population [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/rheumatoid-arthritis-ra-related-joint-symptoms-and-thoracic-bone-mineral-density-in-an-ra-free-community-dwelling-population/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatoid-arthritis-ra-related-joint-symptoms-and-thoracic-bone-mineral-density-in-an-ra-free-community-dwelling-population/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology